Drug
FH 006 For
FH 006 For: highest development phase Phase 1/2, developed by Jiangsu Hengrui Medicine. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Jiangsu Hengrui Medicine
Trials
| Drug | Phase | Indication |
|---|---|---|
| FH-006 for Injection NCT07136142 | Phase 1/2 | Malignant Solid Tumor |
Latest
No recent events.
Follow FH 006 For on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.